[INFO] Processing sample 22
[INFO] Step 1. Single-Agent Few-shot Preparation
[INFO] Step 2. Single-Agent Final Decision
[INFO] Final decision: {0.3: "Let's analyze the question step by step. The patient has been diagnosed with peripheral artery disease (PAD) and is experiencing intermittent claudication, which is characterized by pain in the muscles due to inadequate blood flow during exercise. Cilostazol is a medication commonly used to treat this condition.\n\nCilostazol works primarily as a phosphodiesterase inhibitor. By inhibiting phosphodiesterase type 3 (PDE3), cilostazol increases the levels of cyclic adenosine monophosphate (cAMP) in platelets and vascular smooth muscle cells. This leads to vasodilation and reduced platelet aggregation, which can improve blood flow and alleviate symptoms of claudication.\n\nGiven this mechanism of action, the correct answer is:\n\nAnswer: (E) Phosphodiesterase inhibitor"}

[INFO] API calls for this sample: 5

[INFO] Sample 22 completed successfully